Benign tumours a growing problem

Recent success with targeted therapies to treat benign connective tissue tumours has thrown up important questions, says Professor David Thomas from the Garvan Institute of Medical Research. Using targeted therapies in this way is a completely different scenario to the traditional use in malignant tumours of the connective tissue, he says. “It’s requiring us to ...

Already a member?

Login to keep reading.

© 2021 the limbic